Cognition Therapeutics, Inc. (CGTX) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$7.74M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$8.82M; Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$13.66M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$6.36M*; Operating income -$6.38M; Depreciation and amortization $15.00K*.
Complete source-backed ebitda history.
- Available history
- 2020-12-31 to 2025-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$7.74M | (m) | (m) | (m) | (m) | -$3.05M* | (m) | $5.10M | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$8.82M | (m) | (m) | (m) | (m) | -$5.54M | (m) | $6.12M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$13.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$6.36M* | -$6.38M | $15.00K* | (m) | (m) | (m) | -$5.65M* | (m) | $3.77M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$13.98M | (m) | (m) | (m) | (m) | -$5.62M* | (m) | $11.48M | (m) | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$13.78M | (m) | (m) | (m) | (m) | -$9.88M | (m) | $10.79M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$10.7M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$14.44M* | -$14.46M | $27.00K* | (m) | (m) | $0.00* | -$6.85M* | (m) | $11.39M | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$14.65M* | -$14.68M | $26.00K* | (m) | (m) | (m) | -$6.00M* | (m) | $11.58M | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$14.08M | (m) | (m) | (m) | (m) | (m) | -$7.24M | (m) | $10.55M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$15.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$14.72M* | -$14.74M | $25.00K* | (m) | (m) | $58.00K* | -$4.16M* | (m) | $11.67M | (m) | (m) |
|---|
| 2023-06-30 | Reported | -$11.79M* | -$11.82M | $23.00K* | (m) | (m) | $18.00K* | -$3.70M* | (m) | $8.50M | (m) | (m) |
|---|
| 2023-03-31 | Reported | -$8.95M | (m) | (m) | (m) | (m) | $41.00K | -$2.71M | (m) | $5.43M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$9.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$12.60M* | -$12.63M | $22.00K* | (m) | (m) | $23.00K* | -$4.00K* | (m) | $8.27M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$12.19M* | -$12.21M | $20.00K* | (m) | (m) | $4.00K* | -$5.36M* | (m) | $9.10M | (m) | -$125.00K |
|---|
| 2022-03-31 | Reported | -$9.4M | (m) | (m) | (m) | (m) | $134.00K | -$2.99M | (m) | $6.52M | (m) | $125.00K |
|---|
| 2021-12-31 | Reported | -$11.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$5.20M* | -$5.22M | $23.00K* | (m) | (m) | (m) | -$2.05M* | (m) | $3.67M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$5.96M* | -$5.98M | $24.00K* | (m) | (m) | (m) | -$910.00K* | (m) | $4.89M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$5.56M | (m) | (m) | (m) | (m) | (m) | -$772.00K | (m) | $4.43M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$4.1M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$4.46M | (m) | (m) | (m) | (m) | (m) | (m) | $3.40M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$47.76M | (m) | (m) | (m) | (m) | (m) | -$24.59M | (m) | $37.19M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$53.86M | (m) | (m) | (m) | (m) | $4.00K | -$28.47M | (m) | $41.68M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$50.63M | (m) | (m) | (m) | (m) | $147.00K | -$16.02M | (m) | $37.20M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$43.47M | (m) | (m) | (m) | (m) | $171.00K | -$18.53M | (m) | $30.32M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$28.51M | (m) | (m) | (m) | (m) | $27.00K | -$3.63M | (m) | $18.57M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$17.31M | (m) | (m) | (m) | (m) | $10.00K | -$3.43M | (m) | $12.89M | (m) | (m) |
|---|